NCT03929991

Brief Summary

Up to 1 in 5 women in Africa who deliver their baby by cesarean section get a wound infection. Surgical site infections (SSIs) are largely preventable, but they represent a considerable burden for health-care systems, particularly in low-income and middle-income countries. The prevention of these infections is complex and requires the integration of a range of preventive measures before, during, and after surgery. The aim of the proposed project is to determine the risk factors of Surgical Site Infection post-Cesarean Section in women admitted to Princess Christian Maternity Hospital (PCMH) in Freetown, Sierra Leone. Secondary aims are to determine the incidence of SSI and the predictors of a negative outcome in women with post-CS SSI.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2018

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

April 24, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 29, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2020

Completed
Last Updated

April 30, 2019

Status Verified

April 1, 2019

Enrollment Period

1.4 years

First QC Date

April 24, 2019

Last Update Submit

April 29, 2019

Conditions

Keywords

Site infectionSierra LeoneAfricaCesarean InfectionMaternal Mortality

Outcome Measures

Primary Outcomes (1)

  • Incidence

    To determine the incidence of SSI after CS at PCMH during the study period

    From hospital admission to hospital discharge, an overage of 1 month

Secondary Outcomes (3)

  • Prevalence of Main Features

    From hospital admission to hospital discharge, an overage of 1 month

  • Prevalence of Negative Outcome

    From hospital admission to hospital discharge, an overage of 1 month

  • Screening of Risk factors

    From hospital admission to hospital discharge, an overage of 1 month

Study Arms (2)

Case

All women admitted or already hospitalized with suspected or confirmed infection after C/S will be screened for inclusion in the study as a case. Case confirmation will be clinically established by an infectious disease expert.SSI post C/S will be classified as: * Superficial incisional surgical site infection, * Deep incisional surgical site infection, * Organ/space surgical site infection.

Other: Observational

Control

For each case, 3 patients undergoing the C/S on the same day and admitted to the same ward but not presenting Surgical Site Infection

Other: Observational

Interventions

To record social and clinical characteristics

CaseControl

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsAll women admitted to Princess Christian Maternity Hospital (PCMH) in Freetown, Sierra Leone.
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women undergoing a C/S in an urban tertiary referral maternity hospital PCMH, Freetown (population served: 1'500'000; n. of total deliveries in 2017: 6'861; number of C/S in 2017: 2'028 ).

You may qualify if:

  • All pregnant women undergoing a C/S in on the hospitals during the study period will be eligible to participate in this study.

You may not qualify if:

  • The following conditions will not be considered as outcome, unless they present with systemic repercussion due to infection. For example:
  • Vaginosis, candidiasis
  • Lower tract urinary infection
  • Fungal infections of the skin (athlete's foot, jockitch, ringworm, and yeast infections)
  • Otitis
  • Pharyngitis
  • Herpes simplex, Herpes Zoster (Shingles)
  • Uncomplicated chronic infection
  • Sexually transmitted infections (Gonorrhoea, Syphilis, Trichomonas, Chlamydia, Hepatitis, HIV)
  • Tuberculosis
  • Bacterial colonization (presence of microorganisms without clinical signs/symptoms)
  • Known vaginal, urethral and/or rectal GBS colonization
  • Asymptomatic bacteriuria
  • Known oropharyngeal colonization
  • Non-infectious hypothermia/hyperthermia (e.g. related to epidural, thyroid storm, prostaglandin administration) during hospital stay

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Princess Christian Maternity Hospital

Freetown, Sierra Leone

RECRUITING

MeSH Terms

Conditions

InfectionsMaternal Death

Interventions

Watchful Waiting

Condition Hierarchy (Ancestors)

Parental DeathDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Outcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services Administration

Study Officials

  • Giovanni Putoto, PhD

    Department of operational research Doctors with Africa CUAMM Padova, Italy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Francesco Di Gennaro, MD

CONTACT

Giovanni Putoto, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2019

First Posted

April 29, 2019

Study Start

May 1, 2018

Primary Completion

October 1, 2019

Study Completion

May 1, 2020

Last Updated

April 30, 2019

Record last verified: 2019-04

Locations